Citations

Showing 10 of 108094 citations.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders
Hinson, Shannon R., López‐Chiriboga, A. Sebastian , Bower, James H., Matsumoto, Joseph Y., Hassan, Anhar , Basal, Eati, Lennon, Vanda A. , Pittock, Sean J. , McKeon, Andrew , Pittock, S J , McKeon, Andrew

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | January 25, 2018 | Volume: 5 | Issue: 2 | Pages: No page available

10.1212/nxi.0000000000000438 | PMID 29464188 Get It

Novel hemizygous nonsense mutation in DRP2 is associated with inherited neuropathy
Roda, Ricardo H. , McCray, Brett A. , Hoke, Ahmet, Klein, Christopher J. , Höke, Ahmet

Mayo Clinic

Neurology Genetics | January 25, 2018 | Volume: 4 | Issue: 1 | Pages: No page available

10.1212/nxg.0000000000000220 | PMID 29473052 Get It

Intraregional model for end‐stage liver disease score variation in liver transplantation: Disparity in our own backyard
Croome, Kristopher P. , Lee, David D. , Burns, Justin M. , Taner, C. Burcin , Croome, Kris P , Lee, David D , Keaveny, Andrew P.

Mayo Clinic

Liver Transplantation | January 24, 2018 | Volume: 24 | Issue: 4 | Pages: 488-496

10.1002/lt.25021 | PMID 29365357 Get It

Variation in average Model for End‐Stage Liver Disease (MELD) score at liver transplantation (LT) by United Network for Organ Sharing (UNOS) regions is well documented. The present study aimed to investigate MELD variation at the interregional, intraregional, and intra–donation service area (DSA) levels. Patients undergoing LT between 2015 and 2016 were obtained from the UNOS standard analysis and research file. The distribution of allocation MELD score including median, skew, and kurtosis was examined for all transplant programs. Intraregional median allocation MELD varied significantly within all 11 UNOS regions. The largest variation between programs was seen in region 5 (MELD 24.0 versus 38.5) and region 3 (MELD 20.5 versus 32.0). Regions 1, 5, and 9 had the largest proportion of programs with a highly negative skewed MELD score (50%, 57%, and 57%, respectively), whereas regions 3, 6, 10, and 11 did not have any programs with a highly negative skew. MELD score distribution was also examined in programs located in the same DSA, where no barriers exist and theoretically no significant difference in allocation should be observed. The largest DSA variation in median allocation MELD score was seen in NYRT‐OP1 LiveOnNY (MELD score variation 11), AZOB‐OP1 Donor Network of Arizona (MELD score variation 11), MAOB‐OP1 New England Organ Bank (MELD score variation 9), and TXGC‐OP1 LifeGift Organ Donation Ctr (MELD score variation 9). In conclusion, the present study demonstrates that this MELD disparity is not only present at the interregional level but can be seen within regions and even within DSAs between programs located as close as several city blocks away. Although organ availability likely accounts for a component of this disparity, the present study suggests that transplant center behavior may also play a significant role.Liver Transplantation 24 488–496 2018AASLD.
Spatial variation in high-frequency oscillation rates and amplitudes in intracranial EEG
Cimbálník, Jan , Stead, Matt, Groppe, David M. , Berry, Brent , Křemen, Václav , Kenney‐Jung, Daniel , Brinkmann, Benjamin H. , Guragain, Hari, Berry, Brent M, Kenney-Jung, Daniel, Britton, Jeffrey, Brinkmann, Benjamin H , Kremen, Vaclav , Guragain, H. , Britton, Jeffrey W. , Worrell, Gregory A.

Mayo Clinic

Neurology | January 24, 2018 | Volume: 90 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000004998 | PMID 29367441 Get It

Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues
Khan, Aadil , Paget, James , McLaughlin, Martin , Kyula, Joan , Wilkinson, Michelle, Pencavel, Timothy, Roulstone, Victoria , Seth, Rohit , Halle, Martin , Somaiah, Navita , Boult, Jessica K.R. , Robinson, Simon P. , Pandha, Hardev , Vile, Richard G. , Melcher, Alan , Harrington, Kevin J. , Khan, Aadil A , Paget, James T , Kyula, Joan N , Roulstone, Victoria , Halle, Martin , Boult, Jessica K R , Robinson, Simon P , Melcher, Alan A , Harrington, Kevin , McLaughlin, Martin , Pencavel, Tim D., Mansfield, David , Harris, Paul A.

Mayo Clinic

Science Translational Medicine | January 24, 2018 | Volume: 10 | Issue: 425 | Pages: No page available

10.1126/scitranslmed.aar2041 | PMID 29367346 Get It

Vascular protection using gene therapy can reduce the late toxicities of radiotherapy.
Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm
Perry, Avital , Graffeo, Christopher S. , Marcellino, Chris , Pollock, Bruce E. , Wetjen, Nicholas M. , Meyer, Fredric B. , Graffeo, Christopher Salvatore, Marcellino, Christopher, Marcellino, Christopher

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | January 24, 2018 | Volume: 79 | Issue: 01 | Pages: 091-114

10.1055/s-0038-1625984 | PMID 29404245 Get It

Background Pediatric pituitary adenoma is a rare skull base neoplasm, accounting for 3% of all intracranial neoplasms in children and 5% of pituitary adenomas. Compared with pituitary tumors in adults, secreting tumors predominate and longer disease trajectories are expected due to the patient age resulting in a natural history and treatment paradigm that is complex and controversial. Objectives The aims of this study were to describe a large, single-institution series of pediatric pituitary adenomas with extensive long-term follow-up and to conduct a systematic review examining outcomes after pituitary adenoma surgery in the pediatric population. Methods The study cohort was compiled by searching institutional pathology and operative reports using diagnosis and site codes for pituitary and sellar pathology, from 1956 to 2016. Systematic review of the English language literature since 1970 was conducted using PubMed, MEDLINE, Embase, and Google Scholar. Results Thirty-nine surgically managed pediatric pituitary adenomas were identified, including 15 prolactinomas, 14 corticotrophs, 7 somatotrophs, and 4 non-secreting adenomas. All patients underwent transsphenoidal resection (TSR) as the initial surgical treatment. Surgical cure was achieved in 18 (46%); 21 experienced recurrent/persistent disease, with secondary treatments including repeat surgery in 10, radiation in 14, adjuvant pharmacotherapy in 11, and bilateral adrenalectomy in 3. At the last follow-up (median 87 months, range 3–581), nine remained with recurrent/persistent disease (23%).Thirty-seven publications reporting surgical series of pediatric pituitary adenomas were included, containing 1,284 patients. Adrenocorticotropic hormone (ACTH)-secreting tumors were most prevalent (43%), followed by prolactin (PRL)-secreting (37%), growth hormone (GH)-secreting (12%), and nonsecreting (7%). Surgical cure was reported in 65%. Complications included pituitary insufficiency (23%), permanent visual dysfunction (6%), chronic diabetes insipidus (DI) (3%), and postoperative cerebrospinal fluid (CSF) leak (4%). Mean follow-up was 63 months (range 0–240), with recurrent/persistent disease reported in 18% at the time of last follow-up. Conclusion Pediatric pituitary adenomas are diverse and challenging tumors with complexities far beyond those encountered in the management of routine adult pituitary disease, including nuanced decision-making, a technically demanding operative environment, high propensity for recurrence, and the potentially serious consequences of hypopituitarism with respect to fertility and growth potential in a pediatric population. Optimal treatment requires a high degree of individualization, and patients are most likely to benefit from consolidated, multidisciplinary care in highly experienced centers.
Issues Surrounding Age-Adjusted d-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism
Goodwin, Andrew , Higgins, Russell A. , Moser, Karen , Smock, Kristi J. , Chandler, Wayne L. , Kottke‐Marchant, Kandice, Hartman, Sarah K., Volod, Oksana , Brown, Alan F., Johari, Vandita, Burr, Sharon, Polyakov, Nataliya, Chen, Dong , Goodwin, Andrew J, Moser, Karen A, Johari, Vandita P, Chen, Dong , Brown, Alan F.

Mayo Clinic

Annals of Internal Medicine | January 24, 2018 | Volume: 166 | Issue: 5 | Pages: 361-363

10.7326/m16-2030 | PMID 28024301 Get It

Guideline Update on Evaluation and Selection of Prosthetic Valves
Nishimura, Rick A., Gentile, Federico , Bonow, Robert O.

Mayo Clinic

JAMA Cardiology | January 24, 2018 | Volume: 3 | Issue: 3 | Pages: 260

10.1001/jamacardio.2017.5123 | PMID 29365033 Get It

Surgical Residents and Medical Malpractice—Reply
Zielinski, Martin D. , Thiels, Cornelius A. , Habermann, Elizabeth B.

Mayo Clinic

JAMA Surgery | January 24, 2018 | Volume: 153 | Issue: 4 | Pages: 395

10.1001/jamasurg.2017.5571 | PMID 29365019 Get It

Understanding Pulmonary Stress-Strain Relationships in Severe ARDS and Its Implications for Designing a Safer Approach to Setting the Ventilator
Hubmayr, Rolf D., Kallet, Richard H

Mayo Clinic

Respiratory Care | January 24, 2018 | Volume: 63 | Issue: 2 | Pages: 219-226

10.4187/respcare.05900 | PMID 29367383 Get It

This review describes the current understanding of the lungs' response to deforming stress under conditions of both normal physiology and acute lung injury. Several limiting assumptions are needed to infer lung parenchymal stress and strain from airway pressure, volume, and flow data from mechanically ventilated patients with injured lungs. These assumptions include the effects of the chest wall on lung-surface pressure, its topographical distribution, and the effects of non-uniform tissue properties on local parenchymal stresses. In addition, there is a spectrum of biophysical lung injury mechanisms that involves normal as well as tangential alveolar wall stresses. To these are added important secondary effects on pulmonary vascular resistance and right heart function. Understanding both the assumptions of lung mechanics and the scope of injury mechanisms operating during ARDS is necessary to interpret the results of clinical trials that inform prevailing ventilator-management guidelines. The implications issuing from these 3 topics inform a safer approach to setting and adjusting the ventilator to minimize the risk of ventilator-induced lung injury. This is enumerated in a 5-step approach that can be used to guide ventilator management of unstable patients with severe lung injury.